Integrated analysis of experimental data sets reveals many novel promoters in 1% of the human genome

被引:22
|
作者
Trinklein, Nathan D.
Karaoz, Ulas
Wu, Jiaqian
Halees, Anason
Aldred, Shelley Force
Collins, Patrick J.
Zheng, Deyou
Zhang, Zhengdong D.
Gerstein, Mark B.
Snyder, Michael
Myers, Richard M. [1 ]
Weng, Zhiping
机构
[1] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA
[2] Boston Univ, Bioinformat Program, Boston, MA 02215 USA
[3] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA
[4] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA
[5] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA
关键词
D O I
10.1101/gr.5716607
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The regulation of transcriptional initiation in the human genome is a critical component of global gene regulation, but a complete catalog of human promoters currently does not exist. In order to identify regulatory regions, we developed four computational methods to integrate 129 sets of ENCODE-wide chromatin immunoprecipitation data. They collectively predicted 1393 regions. Roughly 47% of the regions were unique to one method, as each method makes different assumptions about the data. Overall, predicted regions tend to localize to highly conserved, DNase I hypersensitive, and actively transcribed regions in the genome. Interestingly, a significant portion of the regions overlaps with annotated 3'-UTRs, suggesting that some of them might regulate anti-sense transcription. The majority of the predicted regions are > 2 kb away from the 5'-ends of previously annotated human cDNAs and hence are novel. These novel regions may regulate unannotated transcripts or may represent new alternative transcription start sites of known genes. We tested 163 such regions for promoter activity in four cell lines using transient transfection assays, and 25% of them showed transcriptional activity above background in at least one cell line. We also performed 5'-RACE experiments on 62 novel regions, and 76% of the regions were associated with the 5'-ends of at least two RACE products. Our results suggest that there are at least 35% more functional promoters in the human genome than currently annotated.
引用
收藏
页码:720 / 731
页数:12
相关论文
共 50 条
  • [41] Integrated Analysis of the Pancreas and Islets Reveals Unexpected Findings in Human Male With Type 1 Diabetes
    Haliyur, Rachana
    Walker, John T.
    Sanyoura, May
    Reihsmann, Conrad, V
    Shrestha, Shristi
    Aramandla, Radhika
    Poffenberger, Greg
    Ramirez, Andrea H.
    Redick, Sambra D.
    Babon, Jenny Aurielle B.
    Prasad, Nripesh
    Hegele, Robert A.
    Kent, Sally C.
    Harlan, David M.
    Bottino, Rita
    Philipson, Louis H.
    Brissova, Marcela
    Powers, Alvin C.
    JOURNAL OF THE ENDOCRINE SOCIETY, 2021, 5 (12)
  • [42] Integrated analysis reveals the immunotoxicity mechanism of BPs on human lymphocytes
    Zhang, Qiujin
    Li, Mengzhen
    Lin, Xiao
    Lai, Keng Po
    Ding, Zhixiang
    CHEMICO-BIOLOGICAL INTERACTIONS, 2024, 399
  • [43] Evolutionary genome analysis reveals novel pain genes and therapeutic targets
    Neely, G.
    JOURNAL OF NEUROCHEMISTRY, 2015, 134 : 82 - 82
  • [44] The blood genome-wide DNA methylation analysis reveals novel epigenetic changes in human heart failure
    Li, B.
    Feng, Z. -H.
    Sun, H.
    Zhao, Z. -H.
    Yang, S. -B.
    Yang, P.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2017, 21 (08) : 1828 - 1836
  • [45] GENOME WIDE ASSOCIATION ANALYSIS WITH AMINE METABOLITES REVEALS NOVEL LOCI IMPACTING HUMAN METABOLOMIC PROFILES.
    Rotroff, D.
    Yerges-Armstrong, L.
    Lewis, J.
    Beitleshees, A.
    Horenstein, R.
    Shuldiner, A.
    Motsinger-Reif, A.
    Kaddurah-Daouk, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S61 - S61
  • [46] The blood genome-wide DNA methylation analysis reveals novel epigenetic changes in human heart failure
    Li, Bing
    Ping, Yang
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C16 - C16
  • [47] GENOME WIDE ASSOCIATION ANALYSIS WITH AMINE METABOLITES REVEALS NOVEL LOCI IMPACTING HUMAN METABOLOMIC PROFILES.
    Rotroff, D.
    Yerges-Armstrong, L.
    Lewis, J.
    Beitleshees, A.
    Horenstein, R.
    Shuldiner, A.
    Motsinger-Reif, A.
    Kaddurah-Daouk, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S7 - S8
  • [48] Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets
    Q-X Huang
    J-Y Cui
    H Ma
    X-M Jia
    F-L Huang
    L-X Jiang
    Cancer Gene Therapy, 2016, 23 : 48 - 53
  • [49] Screening of potential biomarkers for cholangiocarcinoma by integrated analysis of microarray data sets
    Huang, Q-X
    Cui, J-Y
    Ma, H.
    Jia, X-M
    Huang, F-L
    Jiang, L-X
    CANCER GENE THERAPY, 2016, 23 (2-3) : 48 - 53
  • [50] Integrative Analysis of Epigenome and Transcriptome Data Reveals Aberrantly Methylated Promoters and Enhancers in Hepatocellular Carcinoma
    Huang, Peng
    Xu, Mengxiang
    Han, Haijun
    Zhao, Xinyi
    Li, Ming D.
    Yang, Zhongli
    FRONTIERS IN ONCOLOGY, 2021, 11